Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2026
In Vivo Evaluation of Preoperative Topical Strategies in Reducing Conjunctival Microbial Load before Intravitreal Injections.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cagini Carlo, De Santi Nicola, Solito Chiara, Giugliano Mariarosaria, Mirabella Giuseppe, Ottaviani Matteo, Sari Giorgia, Eslami Varzaneh Giulia, Pietrella Donatella
Аннотация
PURPOSE: To evaluate in vivo efficacy of different topical strategies administered before intravitreal injections (IVIs) in reducing conjunctival microbial load compared with standard preoperative disinfection with 5% povidone-iodine (PI-5%).
METHODS: This prospective randomized comparative study was conducted between January and July 2025 at a tertiary referral ophthalmology center. Patients scheduled for IVIs were randomly assigned to 4 groups: 0.1% Polyquaternium-133, 0.6% povidone-iodine, 0.02% chlorhexidine digluconate, or no preoperative drops [control group (CG)]. Antiseptic eye drops were administered 3 times daily for 3 days before the procedure. Conjunctival swabs were collected at baseline (T0), on the day of injection before standard disinfection (T1), and 3 minutes after PI-5% application (T2). Microbial load was assessed by colony-forming unit (CFU) count, and microorganisms were identified.
RESULTS: A total of 205 patients were enrolled. In the CG, no significant difference was observed between T0 and T1, while PI-5% produced a significant CFU reduction at T2. Preoperative treatment with 0.6% povidone-iodine or 0.02% chlorhexidine digluconate did not significantly reduce CFU counts at T1. In contrast, 0.1% Polyquaternium-133 resulted in a significant reduction in bacterial load between T0 and T1, with a further decrease after PI-5%. Qualitative analysis showed selective effects of antiseptics on conjunctival microbial composition, with Polyquaternium-133 demonstrating marked activity against predominant species, including Corynebacterium macginleyi and Staphylococcus aureus.
CONCLUSIONS: Complete conjunctival sterility was not achieved with any regimen. However, 0.1% Polyquaternium-133 significantly reduced conjunctival bacterial load and showed a complementary effect when combined with standard PI-5% disinfection, suggesting potential clinical benefit in prophylaxis.
METHODS: This prospective randomized comparative study was conducted between January and July 2025 at a tertiary referral ophthalmology center. Patients scheduled for IVIs were randomly assigned to 4 groups: 0.1% Polyquaternium-133, 0.6% povidone-iodine, 0.02% chlorhexidine digluconate, or no preoperative drops [control group (CG)]. Antiseptic eye drops were administered 3 times daily for 3 days before the procedure. Conjunctival swabs were collected at baseline (T0), on the day of injection before standard disinfection (T1), and 3 minutes after PI-5% application (T2). Microbial load was assessed by colony-forming unit (CFU) count, and microorganisms were identified.
RESULTS: A total of 205 patients were enrolled. In the CG, no significant difference was observed between T0 and T1, while PI-5% produced a significant CFU reduction at T2. Preoperative treatment with 0.6% povidone-iodine or 0.02% chlorhexidine digluconate did not significantly reduce CFU counts at T1. In contrast, 0.1% Polyquaternium-133 resulted in a significant reduction in bacterial load between T0 and T1, with a further decrease after PI-5%. Qualitative analysis showed selective effects of antiseptics on conjunctival microbial composition, with Polyquaternium-133 demonstrating marked activity against predominant species, including Corynebacterium macginleyi and Staphylococcus aureus.
CONCLUSIONS: Complete conjunctival sterility was not achieved with any regimen. However, 0.1% Polyquaternium-133 significantly reduced conjunctival bacterial load and showed a complementary effect when combined with standard PI-5% disinfection, suggesting potential clinical benefit in prophylaxis.